Jefferies Starts Kezer Life Sciences (KZR) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Cowen Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:42 AM EDTCowen initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating.
Analyst Phil Nadeau comments "KZR-616 is a selective immunoproteasome inhibitor in development for autoimmunity. It is in Ph. Ib in lupus with data expected in H1:19. Proteasome... More
Wells Fargo Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:25 AM EDTWells Fargo initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating and a price target of $30.00.
Analyst Jim Birchenough comments "Our positive rating and outlook is based on what we view as a highly leverageable platform and pipeline of novel immunoproteasome inhibitors... More
William Blair Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:19 AM EDTWilliam Blair initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating.
For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.
Shares of Kezer Life Sciences closed at $15.80 yesterday.
... More